AnalystsCarly KenselaarCarly Kenselaar's Stock Forecasts
AnalystsCarly Kenselaar
Sectors:
Industries:
Analyst Ranking
Top 33%
#1632 out of 4929 analysts
Average Return
+40.15%
Win Rate
83%5 out of 6
Risk vs Reward
Poor
Good
Carly Kenselaar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | +161.76% | $7.40 | $19.37 | 2023-12-04 - 2024-12-04 | Strong Buy |
Krystal Biotech IncKRYS | +61.22% | $110.85 | $178.71 | 2023-10-11 - 2024-10-11 | Strong Buy |
Travere Therapeutics IncTVTX | +36.70% | $10.98 | $15.01 | 2024-09-05 - 2025-07-03 | Strong Buy |
Travere Therapeutics IncTVTX | +7.14% | $14.01 | $15.01 | 2024-09-26 - 2025-07-03 | Strong Buy |
Travere Therapeutics IncTVTX | +3.37% | $14.52 | $15.01 | 2025-06-10 - 2025-07-03 | Strong Buy |
Carly Kenselaar Analyst Color
Get additional color on Carly Kenselaar's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.